UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN DIVISION OF INTERCOLLEGIATE ATHLETICS STUDENT-ATHLETE ALCOHOL AND DRUG EDUCATION AND DRUG TESTING PROGRAM A. Overview The Division of Intercollegiate Athletics (DIA) at the University of Illinois believes that the use of alcohol and drugs can impair mental and physical performance and have a negative effect on the health and safety of student-athletes. This program is designed to deal with this critical area. The DIA has educational programs in place for student-athletes to increase their awareness of the dangers of drug and alcohol abuse. All coaches within the DIA attend lectures where the Drug Testing Policy and Procedures are explained. These educational programs are augmented by a drug testing program administered under the authority of the Team Physician. All student-athletes shall be asked to submit urine specimens to be analyzed under medical procedures designated by the Team Physician. B. Purpose of Drug Testing The DIA believes that random drug testing and testing based on reasonable suspicion are appropriate to ensure the health, safety and welfare of our student-athletes, to promote fair competition in intercollegiate athletics, to affirm compliance with applicable rules and regulation on drug and alcohol abuse, to identify student-athletes who are improperly using drugs or alcohol and to assist them before they harm themselves or others. Furthermore, the DIA recognizes its responsibility to provide educational programing that will support a positive decision-making process. The intent of these policies is to prevent substance use and abuse by student-athletes through education, testing and professional guidance: Education: providing student-athletes and athletics staff with accurate information about the problems associated with substance use in sport, promoting health and safety in sport. Testing: analyzing biological specimens to detect prohibited substance studentathletes may introduce into their bodies and punitive consequences resulting from use. Professional Referral: facilitating appropriate treatment and counseling of studentathletes. 1
C. Alcohol, Tobacco and Other Drug Education Student-athletes who are educated about substance use in sport are more likely to make informed and intelligent decisions about usage. The DIA will conduct drug and alcohol educations programs for student-athletes regularly. These educational programs will review athletic department, institutional, conference and NCAA policies related to the use of alcohol, tobacco and other drugs. The programs will also address the institutional drug testing program as well as dietary supplements and their risks. Athletic department staff members are also encouraged to attend the educational sessions. Educational materials will also be made available for coaches, athletics staff and student-athletes at any time through the year. D. Consent to Participate Conditional to participation in intercollegiate athletics at University of Illinois, each student-athlete will be required to sign a consent form agreeing to undergo drug and alcohol testing. A copy of this consent form will be kept on file in the Director of Compliance s office. Failure regarding the information contained in the policy, the testing program, or other to consent to or to comply with the requirements of this policy will result in suspension from participation or termination of eligibility to participate in intercollegiate athletics at University of Illinois. Each student-athlete will be given a copy of the institutional policy and will be required to participate in an informative session describing alcohol, tobacco and other drug education and testing policies. Additionally, student-athletes will be given an opportunity to ask any questions related issues prior to signing the drug-testing consent form. E. Use of Dietary Supplements Many dietary supplements or ergogenic aide may contain banned substances. Often the labeling of dietary supplements is inaccurate and misleading. Terms such as healthy or all natural do not mean dietary supplements are free of banned substances or are safe to take. Using dietary supplements may lead to negative side effects such as dehydration and may cause positive drug tests. Student-athletes who are currently taking or intend to take dietary supplements are required to have the product reviewed by the Director of Sports Nutrition and/or the Director of Sports Medicine. Student-athletes are encouraged to contact the National Center for Drug Free Sport at www.drugfeesport.com and the Dietary Supplement Resource Exchange Center (REC) at www.drugfreesport.com/rec for additional information on dietary supplements or other banned supplements. F. Tobacco Policy The NCAA and the University of Illinois prohibit the use of tobacco products by all game personnel (e.g. coaches, student-athletes, athletic trainer, managers and game officials) in all sports during practice and competition. See NCAA Bylaws 11.1.5 and 17.1.7. A 2
student-athlete who violates this tobacco policy shall be disqualified for the remainder of that practice or competition. The Director of Athletics or his/her designee will sanction other game personnel (e.g. head or assistant coach) who violate this tobacco policy on a case-by-case basis. G. Prohibited Drugs/Substances The DIA drug screening process may include an analysis of, but not limited to the NCAA list of banned-drug classes. The NCAA banned drug classes are as follows: stimulants, anabolic agents, diuretics, street drugs, peptide hormones and their related compounds, anti-estrogens and beta 2-Agonists. For ongoing updated listings, student-athletes are urged to review the NCAA s web site at www.ncaa.org or contact the Director of Sports Medicine or their specific sport s athletic trainer. Additional substances that the DIA may screen for include alcohol, beta blockers, opiates (e.g. heroin, hydrocodone, and oxycodone), MDMA (Ecstasy), amphetamine/methamphetamine, synthetic cannabinoids (Spice), synthetic cathinones (Bath Salts) and methylhexaneamin (DMAA). The DIA reserves the right to test for substances not listed on the NCAA Banned Drug Classes list and to test at detection levels that vary from those of the NCAA. The DIA s Student-Athlete Drug Education and Drug Testing Program is separate and distinct from the Big 10 s and NCAA s drug testing programs in areas including, but not limited to, banned substances, sanctions imposed, and levels of detection. H. Methods of Selection for Drug Testing 1. Unannounced Random Testing: All student-athletes who have signed the institutional drug-testing consent form and are listed on the institutional squad list are subject to unannounced random testing. Students listed on the squad list that have exhausted their eligibility will not be selected for testing. All other studentathletes are subject to testing. The Director of Athletics or his/her designee will select student-athletes from the official institutional squad lists by using a computerized random number program. Urinalysis testing procedures may be used for unannounced random testing. 2. Pre-season Screening: Student-athletes are subject to pre-season drug testing and may be notified of such by the Director of Athletics or his/her designee at any time prior to their first competition. 3. Reasonable Suspicion Screening: A student-athlete may be subject to testing at any time when the Director of Athletics or his/her designee determines there is individualized reasonable suspicion to believe the participant is using a banned substance. Such reasonable suspicion may be based on objective information as determined by the Director of Athletics or by an Associate/Assistant Athletic 3
Director, Head Coach, Assistant Coach, Head Athletic Trainer, Assistant Athletic Trainer, or Team Physician, and deemed reliable by the Director of Athletics or his/her designee. Reasonable suspicion may be found, but not limited to 1) observed possession or use of substances appearing to be prohibited drugs, 2) arrest or conviction for a criminal offense related to the possession or transfer of prohibited drugs or substances, or 3) observed abnormal appearance, conduct or behavior reasonably interpretable as being caused by the use of prohibited drugs or substances. Among the indicators which may be used in evaluating a studentathlete s abnormal appearance, conduct or performance are: class attendance, significant GPA changes, athletic practice attendance, increased injury rate or illness, physical appearance changes, academic/athletic motivational level, emotional condition, mood changes, and legal involvement. If suspected, the Director of Athletics or his/her designee will notify the student-athlete and the student-athlete must stay with a member of his/her coaching staff, the athletics administration staff, or the sports medicine staff, until an adequate specimen is produced. Note: The possession and/or use of illegal substances may be determined by means other than urinalysis (e.g., using on-site saliva testing products to determine alcohol consumption). When an individual is found to be in possession and/or using such substances, he/she will be subject to the same procedures that would be followed in the case of a positive urinalysis. 4. Postseason/Championship Screening: Any participant or team likely to advance to post-season championship competition may be subject to additional testing. Testing may be required of all team members or individual student-athletes at any time within thirty (30) days prior to the post-season competition. If a studentathlete tests positive, he or she will be re-tested at a future unannounced date. He or she must receive permission from the Director of Athletics to participate in any postseason event. 5. Re-entry Testing: A student-athlete who has had his or her eligibility to participate in intercollegiate athletics at DIA suspended may, at the discretion of the Director of Athletics, be required to undergo re-entry drug and/or alcohol testing prior to regaining eligibility. The Director of Athletics or his/her designee shall arrange for re-entry testing after the counselor or specialist involved in the student-athlete s case indicates that re-entry into the intercollegiate sports program is appropriate. 6. Follow-up Testing: A student-athlete who has returned to participation in intercollegiate sports following a positive drug test under this policy will be subject to follow-up testing. Testing will be unannounced and will be required at a frequency determined by the Athletic Director or his/her designee in consultation with the counselor or specialist involved in the student-athlete s case. 4
New student-athlete testing will commence when their respective team reports for their first official practice prior to the start of classes or after the first day of fall or spring classes, whichever occurs earlier. I. Notification and Reporting for Collections The student-athlete will be notified of and scheduled for testing by the DIA. The Director of Sports Medicine or his/her designee will notify the student-athlete, in person, or by direct telephone contact (e.g. no voice mail messages, not text messages, no emails), of the date, time and location to report for collection. No specific time period is required for notification of student-athletes prior to the administration of any drug test. A student-athlete who refused to provide an adequate urine sample during the testing process, attempts to manipulate (which can include the ingestion of substances (e.g. herbal remedies) or over-hydrating to mask a banned substance), substitute his/her urine sample, or fails to show up at the designed time shall be deemed to be in violation of this policy, and it will be cause for the same sanction(s) as a positive drug test. J. Voluntary Disclosure/Safe Harbor a. A student-athlete who has engaged in prohibited drug or alcohol use is encouraged to seek assistance from the Athletic Department by voluntarily disclosing his or her use. b. If the student-athlete seeks assistance prior to being identified as having violated this policy or being notified that he or she must undergo screening, the impermissible use will not be deemed an offense for purposes of determining sanctions under this policy; however, the student-athlete will be ineligible to participate in intercollegiate sports pending an evaluation. A student-athlete will not be permitted to enter the Safe Harbor Program thirty (30) days prior to NCAA or Conference postseason competition. c. The student-athlete will be required to undergo an evaluation by a substance abuse counselor. The counselor shall determine the appropriate form(s) of intervention and rehabilitation needed by the student-athlete, based on the circumstances of the case. The counselor will provide a summary of his or her findings and recommendations to the Director of Athletics. d. A student-athlete will be permitted to remain in the Safe Harbor Program for a reasonable period of time, not to exceed thirty (30) days, as determined by the treatment plan. However, the student-athlete will not be permitted to return to participation in intercollegiate sports until the counselor has interviewed the studentathlete following the conclusion of the recommended treatment (or stage of treatment, as applicable) and has determined that reentry into intercollegiate sports is appropriate. If the counselor deems it necessary, the student-athlete will be required to undergo drug and/or alcohol testing as part of the reentry evaluation. 5
e. Failing to complete the treatment recommended by the counselor, having a positive test for any banned substance after entering the Safe Harbor Program, or having a positive result on a reentry drug or alcohol test will be deemed a first offense under this policy. f. If the student-athlete regains his or her eligibility to participate in intercollegiate sports, he or she may be required to undergo unannounced follow-up tests at the discretion of the Athletic Director in consultation with the counselor. K. Reporting of Results All student-athlete information and records associated with the University of Illinois education and drug testing program will be confidential and results will be released only to those individuals with a legitimate need to know, as determined by the Director of Athletics. Urine samples will be collected and sent to an independent certified laboratory for analysis. Each sample will be tested to determine if banned drugs or substances are present. Results will be made available to the Director of Sports Medicine. The Director of Sports Medicine will review the results and if there is a positive drug test result, the Director of Sports Medicine will inform the Director of Athletics or his/her designee and the team physician. A confidential meeting will be scheduled to inform the studentathlete of a positive test and include the following people: the student-athlete, the Head Coach of that sport, the sport administrator for that sport, the Director of Sports Medicine and Team Physician. The results of the will be discussed and provide the student-athlete an opportunity to comment on the test results or medical findings and, in particular, to explain why a false positive result may have been received. L. Medical Exception Process The DIA recognizes that some banned substances are used for legitimate medical purposes. Accordingly, the DIA allows exceptions to be made for student-athletes with a documented medical history demonstrating a need for regular use of such a substance. Student-athletes are required to inform their athletic trainer of all medications (prescribed and over-the-counter) and supplements that they are taking. The DIA shall maintain in the student s medical record a letter from the prescribing physician that documents the student-athlete s medical history demonstrating a need for regular use of such a drug. The letter should contain information as to the diagnosis including any special testing (e.g. Neurobehavioral Standard Assessment), medical history and dosage information. 6
In the event a student-athlete tests positive, the Director of Sports Medicine in consultation with the Team physician will review the student-athlete s medical record to determine whether a medical exception should be granted. M. Alcohol and Non-Drug Testing Offenses An alcohol or drug offense is any violation of federal, state or local law as well as any violation of the University of Illinois or DIA alcohol and drug policy. The following offenses may result in immediate suspension and will count as a second positive test as outlined in section N of this policy: DWI/DUI. The following offenses will be evaluated by the Director of Athletics or his/her designee to determine the appropriate sanctions to be imposed, including whether or not they result in a first positive result outlined in section N of this policy: Underage drinking and/or purchasing of alcohol Minor in possession (MIP)/minor consumption Public intoxication Public urination Consumption of alcohol by a student-athlete host and/or their assigned prospective student-athlete during an official recruiting visit *Note that these are not exhaustive lists of drug or alcohol related offenses. N. Actions after positive test for marijuana, synthetic cannabinoids, benzodiazepines (e.g. valium), barbiturates (e.g. phenobarbital), opioids (e.g. hydrocodone, morphine oxycodone etc., (with the exception of heroin). Under medical regulations established by the Big Ten Conference, the Team Physician has final authority to determine whether the student-athlete is medically qualified to participate in practice and competition. The Team Physician s decision shall be made bearing in mind one of the fundamental purposes of the program, namely, protection of the student-athlete s health and safety. 1. After the first positive test for a street drug (marijuana, synthetic cannabinoids, benzodiazepines, barbiturates, opioids (with the exception of heroin)), a meeting with the student-athlete, head coach of that sport, sport administrator of that sport, the Team Physician and Director of Sports Medicine will occur to inform the student-athlete of the positive test. The head coach will inform the student-athlete parents (when appropriate) of the positive test. The Team Physician shall take medically appropriate action which will include a substance abuse evaluation, then if deemed necessary, substance abuse counseling or treatment and other 7
action to protect the health and safety of the student-athlete. The student-athlete will be required to participate in the treatment and education program, which will include weekly drug testing. Failure to comply with treatment programs shall result in disciplinary consequences including but not limited to loss of regular and post season competitions. 2. If the student-athlete tests positive a second time for a street drug (marijuana, synthetic cannabinoids, benzodiazepines, barbiturates, opioids (with the exception of heroin)), this will be considered evidence of a more serious medical and safety problem. A meeting with the student-athlete, head coach of that sport, sport administrator of that sport, the Team Physician and Director of Sports Medicine will occur to inform the student-athlete of the second positive test. The head coach will inform the student-athletes parents (when appropriate) of the positive test. The student-athlete shall be withheld from athletic practice and competition for medical reasons until deemed fit to return by the Team Physician. The student-athlete will also be required to participate in the treatment and education program, which will include weekly drug testing. The student-athlete shall be suspended for a number of consecutive competitions equivalent to a minimum of 25% of their sport program s regular and post season games, matches, or meets immediately following the positive test. If the positive test happens during the student-athletes non-competitive season the suspension will occur at the beginning of the next completive season. Failure to comply with treatment programs shall result in disciplinary consequences including but not limited to loss of additional regular and post season competitions. 3. If the student-athlete tests positive a third time for a street drug (marijuana, synthetic cannabinoids, benzodiazepines, barbiturates, opioids (with the exception of heroin)), this will be considered evidence of a more serious medical and safety problem. A meeting with the student-athlete, head coach of that sport, sport administrator of that sport, the Team Physician and Director of Sports Medicine will occur to inform the student-athlete of the third positive test. The head coach will inform the student-athletes parents (when appropriate) of the positive test. The student-athlete shall be withheld from athletic practice and competition for medical reasons until deemed fit to return by the Team Physician. The studentathlete will also be required to participate in the treatment and education program, which will also include weekly drug testing. The student-athlete shall be suspended for a number of consecutive competitions equivalent to a minimum of 50% of their sport program s regular and post season games, matches, or meets immediately following the positive test. If the positive test happens during the student-athletes non-competitive season the suspension 8
will occur at the beginning of the next completive season. Failure to comply with treatment programs shall result in disciplinary consequences including but not limited to loss of additional regular and post season competitions. 4. If the student-athlete tests positive a fourth time for a street drug (marijuana, synthetic cannabinoids, benzodiazepines, barbiturates, opioids (with the exception of heroin)), this will be considered evidence of a more serious medical and safety problem. A meeting with the student-athlete, head coach of that sport, sport administrator of that sport, the Team Physician and Director of Sports Medicine will occur to inform the student-athlete of the fourth positive test. The head coach will inform the student-athletes parents (when appropriate) of the positive test. The student-athlete shall be withheld from athletic practice and competition for medical reasons until deemed fit to return by the Team Physician. The studentathlete will also be required to participate in the treatment and education program, which will include weekly drug testing. The student-athlete shall loose one season of eligibility (365 days) of their sport program, immediately following the date of the positive test. Prior to reinstatement onto his or her previous athletic team or any other varsity intercollegiate team, the student-athlete must pass a drug screen at the end of the twelve month suspension. Failure to comply with treatment programs shall result in an immediate and indefinite suspension from all practice and competition. O. Actions After Positive Test For Stimulants, (Cocaine, Amphetamines etc.), Heroin, or Any other stimulant type drug Not Prescribed By A Licensed Practicing Medical Provider (e.g. Adderall, Ritalin, etc.) 1. If the student-athlete tests positive for any of the above drugs, a meeting with the student-athlete, head coach of that sport, sport administrator of that sport, the Team Physician and Director of Sports Medicine will occur to inform the studentathlete of the positive test. The head coach will inform the student-athlete parents (when appropriate) of the positive test. The Team Physician shall take medically appropriate action which will include a substance abuse evaluation, then if deemed necessary, substance abuse counseling or treatment and other action to protect the health and safety of the student-athlete. The student-athlete shall be withheld from athletic practice for medical reasons until deemed fit to return by a team physician and a urine drug test is completed and a negative result is obtained. The student-athlete will also be required to participate in the treatment and education program, which will include weekly drug testing. Parents/guardians will be notified when appropriate, and kept informed of progress. A positive test in this category shall also count as positive test under section N of this program. Any additional game suspensions shall be added to any suspension the student- 9
athlete may already be serving for a positive test under section N. The studentathlete shall loose one season of eligibility (365 days) of their sport program, immediately following the date of the positive test. Failure to comply with treatment programs shall result in an immediate and indefinite suspension from all practice and competition. Prior to reinstatement onto his or her previous athletic team or any other varsity intercollegiate team, the studentathlete must pass a drug screen at the end of the twelve month suspension. 2. If the student-athlete tests positive a second time for any of the above drugs, this will be considered evidence of a more serious medical and safety problem. A meeting with the student-athlete, head coach of that sport, sport administrator of that sport, the Team Physician and Director of Sports Medicine will occur to inform the student-athlete of the positive test. The head coach will inform the student-athlete parents (when appropriate) of the positive test. The student-athlete will also be required to participate in the treatment and education program, which will include weekly drug testing. The student-athlete shall be withheld from athletic practice and competition for medical reasons until deemed fit to return by a team physician and a negative drug screen is completed. Parents/guardians will be notified when appropriate, and kept informed of progress. A second positive test in this category shall also count as a positive test under section N of this program. Any additional game suspensions shall be added to any suspension the student-athlete may already be serving for a positive test under section N of this program. The student-athlete shall loose an additional 365 days of eligibility immediately following the positive test. Prior to reinstatement onto his or her previous athletic team or any other varsity intercollegiate team, the student-athlete must pass a drug screen at the end of the 365 day suspension. P. Actions After Positive Test For Anabolic Steroids Or Other Performance Enhancing Drugs 1. If a student-athlete tests positive for any anabolic steroid or other performance enhancing drug a meeting with the student-athlete, head coach of that sport, sport administrator of that sport, the Team Physician and Director of Sports Medicine will occur to inform the student-athlete of the positive test. The head coach will inform the student-athlete parents (when appropriate) of the positive test. The Team Physician shall take medically appropriate action which will include a substance abuse evaluation, then if deemed necessary, substance abuse counseling or treatment and other action to protect the health and safety of the studentathlete. The student-athlete will also be required to participate in the treatment and education program, which will include weekly drug testing. The student athlete shall loose a season of eligibility and withheld from competition in all 10
sports for 365 days from the date of the positive drug test. Failure to comply with treatment programs shall result in an immediate and indefinite suspension from all practices. Prior to reinstatement onto his or her previous athletic team or any other varsity intercollegiate team, the student-athlete must pass a performance enhancing drug screen at the end of the 365 day suspension. 2. If the student-athlete tests positive a second time for any of the above drugs, this will be considered evidence of a more serious medical and safety problem. A meeting with the student-athlete, head coach of that sport, sport administrator of that sport, the Team Physician and Director of Sports Medicine will occur to inform the student-athlete of the positive test. The head coach will inform the student-athlete parents (when appropriate) of the positive test. The student-athlete shall be withheld from athletic practice and competition for medical reasons until deemed fit to return by a team physician and a negative drug screen is completed. The student-athlete will also be required to participate in the treatment and education program, which will include weekly drug testing. Parents/guardians will be notified when test in this category shall also count as a positive test under section N of this appropriate, and kept informed of progress. A second positive program. Any additional game suspensions shall be added to any suspension the student-athlete may already be serving for a positive test under section N of this program. The student-athlete shall lose all additional eligibility immediately following the positive test. Q. Scholarships and Financial Aid A tender for scholarship and financial may not be renewed if the student-athlete is suspended from an athletic team for participating in the use of, sale of, or distribution of any of above drug classes. R. Drug Treatment Program Any student-athlete desiring substance abuse treatment is encouraged to utilize the resources available to all University of Illinois students. These include resources in the Counseling Center and McKinley Health Center. Student Health Insurance also covers some off-campus resources. These off-campus resources are available through referral from the Team Physician or McKinley Health Center. Student-athletes can utilize these resources before, during or after the drug testing program. If the athlete has negative drug screens for a total of 12 months and the medical care team feels the student-athlete no longer requires drug counseling and treatment, further care 11
will be at the student athlete s own expense. Such expenses can also be paid through the appropriate sport program s budget as determined by the Division of Intercollegiate Athletics. Student-athletes can be discharged from treatment at the discretion of the medical treatment team when counseling and treatment requirements have been met. Adopted 1985 Revised 04/30/15 PDS 12